Charles Schwab Investment Management Inc Sarepta Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 623,749 shares of SRPT stock, worth $69.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
623,749
Previous 611,749 1.96%
Holding current value
$69.7 Million
Previous $76.4 Million 0.74%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$104.54 - $137.94 $1.25 Million - $1.66 Million
12,000 Added 1.96%
623,749 $75.8 Million
Q3 2024

Nov 12, 2024
BUY
$124.33 - $156.75 $869,315 - $1.1 Million
6,992 Added 1.16%
611,749 $76.4 Million
Q2 2024

Aug 12, 2024
BUY
$113.33 - $163.85 $1.74 Million - $2.51 Million
15,318 Added 2.6%
604,757 $95.6 Million
Q1 2024

May 08, 2024
BUY
$93.7 - $141.53 $1.22 Million - $1.84 Million
13,027 Added 2.26%
589,439 $76.3 Million
Q4 2023

Feb 06, 2024
BUY
$67.31 - $124.76 $1.08 Million - $2 Million
16,061 Added 2.87%
576,412 $55.6 Million
Q3 2023

Nov 08, 2023
BUY
$102.5 - $123.59 $646,672 - $779,729
6,309 Added 1.14%
560,351 $67.9 Million
Q2 2023

Aug 09, 2023
BUY
$106.4 - $157.19 $3.63 Million - $5.36 Million
34,078 Added 6.55%
554,042 $63.4 Million
Q1 2023

May 11, 2023
BUY
$117.53 - $155.99 $411,942 - $546,744
3,505 Added 0.68%
519,964 $71.7 Million
Q4 2022

Feb 13, 2023
BUY
$100.86 - $132.13 $2.2 Million - $2.88 Million
21,819 Added 4.41%
516,459 $66.9 Million
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $528,910 - $833,010
6,986 Added 1.43%
494,640 $54.7 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $524,652 - $740,154
8,369 Added 1.75%
487,654 $36.6 Million
Q1 2022

May 13, 2022
BUY
$63.15 - $90.42 $695,028 - $995,162
11,006 Added 2.35%
479,285 $37.4 Million
Q4 2021

Feb 11, 2022
BUY
$77.28 - $99.42 $3.83 Million - $4.93 Million
49,620 Added 11.85%
468,279 $42.2 Million
Q3 2021

Nov 16, 2021
BUY
$65.97 - $92.48 $980,710 - $1.37 Million
14,866 Added 3.68%
418,659 $38.7 Million
Q2 2021

Aug 16, 2021
BUY
$69.38 - $86.75 $649,466 - $812,066
9,361 Added 2.37%
403,793 $31.4 Million
Q1 2021

May 17, 2021
BUY
$72.25 - $168.95 $287,771 - $672,927
3,983 Added 1.02%
394,432 $29.4 Million
Q4 2020

Feb 16, 2021
BUY
$125.56 - $178.74 $748,588 - $1.07 Million
5,962 Added 1.55%
390,449 $66.6 Million
Q3 2020

Nov 13, 2020
BUY
$127.12 - $172.34 $3.09 Million - $4.19 Million
24,308 Added 6.75%
384,487 $54 Million
Q2 2020

Aug 14, 2020
BUY
$93.0 - $171.7 $2.06 Million - $3.81 Million
22,178 Added 6.56%
360,179 $57.8 Million
Q1 2020

May 15, 2020
BUY
$82.38 - $131.64 $593,959 - $949,124
7,210 Added 2.18%
338,001 $33.1 Million
Q4 2019

Feb 07, 2020
BUY
$76.53 - $135.58 $444,409 - $787,313
5,807 Added 1.79%
330,791 $42.7 Million
Q3 2019

Nov 08, 2019
BUY
$72.81 - $156.91 $1.35 Million - $2.91 Million
18,575 Added 6.06%
324,984 $24.5 Million
Q2 2019

Aug 09, 2019
BUY
$112.21 - $151.95 $2.8 Million - $3.79 Million
24,932 Added 8.86%
306,409 $46.6 Million
Q1 2019

May 14, 2019
BUY
$106.67 - $151.68 $2.04 Million - $2.9 Million
19,091 Added 7.28%
281,477 $33.6 Million
Q4 2018

Feb 14, 2019
BUY
$97.32 - $148.76 $2.35 Million - $3.59 Million
24,140 Added 10.13%
262,386 $28.6 Million
Q3 2018

Nov 13, 2018
BUY
$115.31 - $161.51 $1.14 Million - $1.6 Million
9,915 Added 4.34%
238,246 $38.5 Million
Q2 2018

Aug 08, 2018
SELL
$71.74 - $153.69 $6.61 Million - $14.2 Million
-92,125 Reduced 28.75%
228,331 $30.2 Million
Q1 2018

May 07, 2018
BUY
$54.02 - $82.27 $1.68 Million - $2.56 Million
31,107 Added 10.75%
320,456 $23.7 Million
Q4 2017

Jan 17, 2018
BUY
$47.64 - $56.75 $990,721 - $1.18 Million
20,796 Added 7.74%
289,349 $16.1 Million
Q3 2017

Nov 13, 2017
BUY
$35.73 - $47.15 $9.6 Million - $12.7 Million
268,553
268,553 $12.2 Million

Others Institutions Holding SRPT

# of Institutions
528
Shares Held
85M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.79B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email